Iska Avitan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Iska Avitan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abraham Olivier Samson
Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel
1 shared publication - Baruh Polis
Azrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel
1 shared publication - Dana Atrahimovich
Department of Natural Compounds and Analytical Chemistry, MIGAL—Galilee Research Institute, Kiryat Shmona 11016, Israel
1 shared publication - Naamah Bloch
Azrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel
1 shared publication - Ori Braitbard
Bioinformatics Department, Jerusalem College of Technology, Jerusalem 9548311, Israel
1 shared publication - Trishna Saha Detroja
The Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel
1 shared publication
Latest Publications
- Open Access
- 24 September 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (19) , 4360
Towards a Consensus on Alzheimer’s Disease Comorbidity?
Alzheimer’s disease (AD) is often comorbid with other pathologies. First, we review shortly the diseases most associated with AD in the clinic. Then we query PubMed citations for the co-occurrence of AD with other diseases, using a list of 400 common pathologies. Significantly, AD is found to be associated with schizophrenia and psychosis, sleep insomnia and apnea, type 2 diabetes, atherosclerosis, hypertension, cardiovascular diseases, obesity, fibrillation, osteoporosis, arthritis, glaucoma, metabolic syndrome, pain, herpes, HIV, alcoholism, heart failure, migraine, pneumonia, dyslipidemia, COPD and asthma, hearing loss, and tobacco smoking. Trivially, AD is also found to be associated with several neurodegenerative diseases, which are disregarded. Notably, our predicted results are consistent with the previously published clinical data and correlate nicely with individual publications. Our results emphasize risk factors and promulgate diseases often associated with AD. Interestingly, the comorbid diseases are often degenerative diseases exacerbated by reactive oxygen species, thus underlining the potential role of antioxidants in the treatment of AD and comorbid diseases.
- 24 September 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (19) , 4360
Open AccessTowards a Consensus on Alzheimer’s Disease Comorbidity?
Alzheimer’s disease (AD) is often comorbid with other pathologies. First, we review shortly the diseases most associated with AD in the clinic. Then we query PubMed citations for the co-occurrence of AD with other diseases, using a list of 400 common pathologies. Significantly, AD is found to be associated with schizophrenia and psychosis, sleep insomnia and apnea, type 2 diabetes, atherosclerosis, hypertension, cardiovascular diseases, obesity, fibrillation, osteoporosis, arthritis, glaucoma, metabolic syndrome, pain, herpes, HIV, alcoholism, heart failure, migraine, pneumonia, dyslipidemia, COPD and asthma, hearing loss, and tobacco smoking. Trivially, AD is also found to be associated with several neurodegenerative diseases, which are disregarded. Notably, our predicted results are consistent with the previously published clinical data and correlate nicely with individual publications. Our results emphasize risk factors and promulgate diseases often associated with AD. Interestingly, the comorbid diseases are often degenerative diseases exacerbated by reactive oxygen species, thus underlining the potential role of antioxidants in the treatment of AD and comorbid diseases.